51 results
8-K
6iztyj33
17 Nov 23
Dermata Announces Exercise of Warrants for $2.26 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
4:06pm
8-K
EX-4.1
w0vv7rz
17 Nov 23
Dermata Announces Exercise of Warrants for $2.26 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
4:06pm
8-K
EX-4.2
gtwktsnxehkagkfu7x78
17 Nov 23
Dermata Announces Exercise of Warrants for $2.26 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
4:06pm
424B4
clpmi4
27 Jul 23
Prospectus supplement with pricing info
4:50pm
424B5
7bksrl5fju
25 May 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-4.1
t87fgth4
24 May 23
Dermata Therapeutics Announces $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules
5:13pm
8-K
EX-4.2
s0v7s5z 99qi
24 May 23
Dermata Therapeutics Announces $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules
5:13pm
8-K
EX-4.3
skgu79z2xb
24 May 23
Dermata Therapeutics Announces $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules
5:13pm
S-3
mi2n459n
15 Nov 22
Shelf registration
4:06pm
DEF 14A
aa7okp4de
1 Jun 22
Definitive proxy
4:20pm
PRE 14A
uwvwr2d95511149icgs
20 May 22
Preliminary proxy
4:05pm